Face-down position may be safer during radiation for breast cancer: study

September 6, 2012 by Kathleen Doheny, Healthday Reporter
Face-down position may be safer during radiation for breast cancer: study
Findings suggest prone position might reduce exposure of heart, lungs.

(HealthDay)—Changing the position of a patient while receiving radiation therapy for breast cancer may reduce the later risks of heart and lung problems, according to a new study.

patients who get after breast-conserving surgery typically are placed in a supine, or face-up, position, said study leader Dr. Silvia Formenti, chairwoman of the department of radiation oncology and associate director of the NYU Cancer Institute at the New York University School of Medicine and Langone Medical Center in New York City.

Her new study, which included 400 patients, suggested the prone, or face-down, position may be better for most.

"Radiation oncology centers should develop the expertise to treat prone," she said. The study was published as a research letter Sept. 5 in the .

Of the 400 in the study, half had cancer in the right breast and half in the left breast. Most of the women (nearly 79 percent) had . Of those, about 15 percent had lymph node involvement. The average age was about 56.

All the women had two CT simulation scans, first supine and then prone.

Simulation scans are used to help doctors visualize structures such as the and lungs and help them make a plan about the best treatment position to target the cancer effectively while sparing normal tissue as much as possible. Formenti compared how well each position would spare the heart and from radiation.

She found for all patients that the prone position was linked to less exposure of the lungs than the supine position. In those with cancer of the left breast, the prone position was linked to a reduced exposure to the heart.

Formenti found, however, that in 15 percent of women with cancer of the left breast, supine positioning was better.

"The minority better off in supine position (15 percent in our study) was more likely to have a very small breast," Formenti said.

" should first be simulated prone," she said. "If some of the heart is in the field [to be irradiated] when prone ... they should then be simulated supine to see whether they are better off in the standard supine position."

Dr. Nayana Vora, clinical professor of radiation oncology at the City of Hope Comprehensive Cancer Center in Duarte, Calif., agreed somewhat with the conclusions.

"I think in selected cases this is a good idea," she said, such as if the cancer has not spread to the lymph nodes. She said treatment planning is done first, to decide which position is best for each patient.

"The majority of our [patients] still get supine," she said. "It is more comfortable for patients."

It is possible to block the irradiation to the heart and other structures by using a shield-like device, she said.

"In selected cases we do prone," she said, but some women are not comfortable in this position. Although each session is only about 10 minutes, women usually undergo treatment for about six weeks, she said.

"Personal comfort has to be taken into account," she said, but never at the expense of risks to the heart and lungs.

The authors noted that their study was limited to a single institution and a multi-institutional study would be needed to confirm the findings.

Explore further: Accelerated radiation treatment effective for noninvasive breast cancer

More information: The Radiological Society of North America and American College of Radiology have more about simulation in external beam radiation treatment.

Related Stories

Accelerated radiation treatment effective for noninvasive breast cancer

June 29, 2012
Accelerated whole breast irradiation after lumpectomy is an effective treatment for ductal carcinoma in situ (DCIS), a very common early stage and noninvasive form of breast cancer, meaning many more breast cancer patients ...

Breast cancer surgery patients benefit from adding radiation therapy

June 4, 2011
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study ...

Radiation after lumpectomy helps prevent need for mastectomy in early stage breast cancer

August 13, 2012
Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will not need a mastectomy in the future. That is the conclusion of ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.